Hologic Stock Forecast for 2023 - 2025 - 2030
Updated on 12/06/2023
Hologic Stock Forecast and Price Target
In recent months, three notable analysts have provided yearlong price targets for Hologic, with the average target coming in at $78.50. If it were to be achieved, this would result in a potential upside of approximately 13.34 percent from the most recent closing price in December, 2023. The high end is $95.00, and the low is $70.00. If you're interested in HOLX stock, it's important to compare it to other companies in the industry.
13.34% Upside
Hologic Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Hologic's Price has seen an increase, rising from $38.27 to $62.37. This represents a growth of 62.96%. Analysts predict that Hologic's Fair Value will increase in the upcoming year, reaching $67.41. This would represent an increase of 8.08%. Over the next seven years, experts predict that Hologic's Fair Value will grow at a rate of 43.16%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ROG Stock Forecast | Roche Holding | Hold |
3
|
CHF250.95 | Buy/Sell | CHF384.23 | 15.56% |
| NOVN Stock Forecast | Novartis | Outperform |
9
|
CHF85.06 | Buy/Sell | CHF103.75 | 19.17% |
| ABT Stock Forecast | Abbott Laboratories | Outperform |
10
|
$104.35 | Buy/Sell | $116.25 | 10.49% |
| PFE Stock Forecast | Pfizer Inc | Outperform |
3
|
$29.09 | Buy/Sell | $40.55 | 27.19% |
| DHR Stock Forecast | Danaher Corp | Outperform |
10
|
$219.44 | Buy/Sell | $245.74 | 9.37% |
Hologic Revenue Forecast for 2023 - 2025 - 2030
In the last four years, Hologic's Revenue has seen an increase, rising from $3.37B to $4.03B. This represents a growth of 19.69%. Analysts predict that Hologic's Revenue will increase in the upcoming year, reaching $4.37B. This would represent an increase of 8.37%. Over the next seven years, experts predict that Hologic's Revenue will grow at a rate of 49.15%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GE Stock Forecast | General Electric | Outperform |
9
|
$120.23 | Buy/Sell | $131.00 | 11.04% |
| SIE Stock Forecast | Siemens | Outperform |
10
|
158.74€ | Buy/Sell | 185.25€ | 13.39% |
| ISRG Stock Forecast | Intuitive Surgical Inc | Outperform |
15
|
$309.52 | Buy/Sell | $360.83 | 4.19% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BMY Stock Forecast | Bristol-Myers Squibb Co | Outperform |
2
|
$50.23 | Buy/Sell | $64.13 | 22.44% |
| GSK Stock Forecast | GSK | Outperform |
12
|
£14.40 | Buy/Sell | £17.30 | 12.50% |
| BDX Stock Forecast | Becton Dickinson and Co | Outperform |
9
|
$233.60 | Buy/Sell | $301.27 | 19.86% |
Hologic Free Cash Flow Forecast for 2023 - 2025 - 2030
Hologic's Free Cash Flow has grown in the last four years, jumping from $540.40M to $954.40M – an increase of 76.61%. In the next year, analysts predict that Free Cash Flow will reach $1.10B – an increase of 15.36%. For the next seven years, the forecast is for Free Cash Flow to grow by 67.10%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| RKT Stock Forecast | Reckitt Benckiser Group | Outperform |
16
|
£54.14 | Buy/Sell | £67.96 | 21.72% |
| IDXX Stock Forecast | IDEXX Laboratories Inc | Outperform |
16
|
$518.95 | Buy/Sell | $553.92 | 3.04% |
| EW Stock Forecast | Edwards Lifesciences Corp | Outperform |
11
|
$68.85 | Buy/Sell | $80.22 | 16.19% |
Hologic Net Income Forecast for 2023 - 2025 - 2030
In the last four years, Net Income for Hologic has grown by 323.97%, going from $-203.60M to $456.00M. In the coming year, analysts are expecting an increase in Net Income, predicting it will reach $1.08B – an increase of 136.03%. Over the next seven years, experts anticipate that Net Income growth for Hologic will be 191.90%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A Stock Forecast | Agilent Technologies | Outperform |
17
|
$127.88 | Buy/Sell | $132.86 | 5.57% |
| ALC Stock Forecast | Alcon | Outperform |
15
|
CHF63.02 | Buy/Sell | CHF0.00 | 46.59% |
| MTD Stock Forecast | Mettler-Toledo International I... | Hold |
13
|
$1.08k | Buy/Sell | $1.39k | -1.10% |
Hologic EBITDA Forecast for 2023 - 2025 - 2030
In the last four years, Hologic's EBITDA has increased by 24.28%, going from $1.03B to $1.28B. In the next year, analysts are expecting an increase in EBITDA, predicting it will reach $1.55B – an increase of 21.31%. The Hologic forecast is for EBITDA to reach $1.92B or grow by 49.88%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| RMD Stock Forecast | ResMed Inc | Outperform |
17
|
$160.95 | Buy/Sell | $220.76 | 8.11% |
| 7733 Stock Forecast | Olympus | Outperform |
18
|
¥2.09k | Buy/Sell | ¥0.00 | 15.08% |
| 7751 Stock Forecast | Canon | Hold |
18
|
¥3.81k | Buy/Sell | ¥0.00 | -2.99% |
Hologic EBIT Forecast for 2023 - 2025 - 2030
In the last four years, Hologic's EBIT has grown, increasing from $568.20M to $958.30M – an increase of 68.66%. For next year, the 5 analysts predict EBIT of $1.45B, which would mean an increase of 51.10%. Over the next seven years, the pros' prediction is EBITof $2.22B, which would mean a seven-year growth forecast of 132.10%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| STE Stock Forecast | STERIS | Outperform |
13
|
$198.55 | Buy/Sell | $240.83 | 23.39% |
| LH Stock Forecast | Laboratory Corp of America Hol... | Outperform |
11
|
$217.02 | Buy/Sell | $278.38 | 9.41% |
| 4901 Stock Forecast | FUJIFILM Holdings | Buy |
18
|
¥8.52k | Buy/Sell | ¥0.00 | 22.61% |
Hologic EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Hologic's EPS has seen an increase, rising from $2.43 to $3.96. This represents a growth of 62.96%. Analysts predict that Hologic's EPS will increase in the upcoming year, reaching $4.28. This would represent an increase of 8.08%. Over the next seven years, experts predict that Hologic's EPS will grow at a rate of 43.16%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DGX Stock Forecast | Quest Diagnostics Inc | Hold |
10
|
$134.89 | Buy/Sell | $145.80 | 3.79% |
| PHIA Stock Forecast | Koninklijke Philips N.V. | Hold |
18
|
18.48€ | Buy/Sell | 50.07€ | 2.81% |
| SN. Stock Forecast | Smith & Nephew | Outperform |
18
|
£10.26 | Buy/Sell | £15.98 | 58.97% |
.jpg)